Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-07-03

Clinical Trial Update: Evaluation of DeltaMaxx® Microcoil System in Intracranial Aneurysms

View source ↗

Summary

A clinical trial evaluating the DeltaMaxx Microcoil System for intracranial aneurysms has been withdrawn from the registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DeltaMaxx Microcoil System

Snippet

Sponsor: Codman & Shurtleff | Conditions: Intracranial Aneurysms | Status: WITHDRAWN